AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2022
Jun 18, 2022
32853_dirs_2022-06-17_a8ebef21-8bfb-41dd-a4bb-c948a8ea6c1f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-06-15
Reporting Person: Clague Laura (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-15 | Common Stock | A | 30914 | — | Acquired | 78415 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-06-15 | Stock Option (Right to Buy) | $1.86 | A | 42571 | Acquired | 2032-06-15 | Common Stock (42571.0) | Direct |
Footnotes
F1: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders. The Reporting Person has deferred settlement of the Restricted Stock Units until the earlier to occur of the Reporting Person's termination of service and a change of control.
F2: Represents Restricted Stock Units with respect to which the Reporting Person has deferred settlement as described above.
F3: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022.